Status:
COMPLETED
The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery
Lead Sponsor:
Hospital for Special Surgery, New York
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Blood Loss
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if the agent, Floseal, can decrease the amount of blood patients lose after total knee replacement (TKR) surgery. If this product can be found to have an effe...
Detailed Description
This is a prospective double blind randomized clinical trial of patients requiring unilateral total knee arthroplasty. The patients will be randomized intra-operatively to receiving Floseal or no trea...
Eligibility Criteria
Inclusion
- Single Knee replacement for arthritis of the knee
Exclusion
- No inflammatory arthritis (ie. Rheumatoid arthritis)
- No allergies to cow meat (bovine allergies
- No history of bleeding disorders
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT00990288
Start Date
October 1 2007
End Date
August 1 2010
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021